GT200500106A - Derivados de benceno halogenados sustituidos con trimeros macrociclicos - Google Patents

Derivados de benceno halogenados sustituidos con trimeros macrociclicos

Info

Publication number
GT200500106A
GT200500106A GT200500106A GT200500106A GT200500106A GT 200500106 A GT200500106 A GT 200500106A GT 200500106 A GT200500106 A GT 200500106A GT 200500106 A GT200500106 A GT 200500106A GT 200500106 A GT200500106 A GT 200500106A
Authority
GT
Guatemala
Prior art keywords
benchen
macrociclic
trimers
halogenated
derivatives replaced
Prior art date
Application number
GT200500106A
Other languages
English (en)
Inventor
Juan R Harto
Jose L Martin
Johannes Platzek
Heiko Schirmer
Hanns-Joachim Weinmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200500106A publication Critical patent/GT200500106A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE LA FORMULA GENERAL I EN LA QUE HAL, A1,A2, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. ESTOS COMPUESTOS SON DE UTILIDAD COMO SUSTANCIAS DE CONTRASTE EN EL DIAGNOSTICO POR RAYOS X Y TRM.
GT200500106A 2004-05-05 2005-05-04 Derivados de benceno halogenados sustituidos con trimeros macrociclicos GT200500106A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004023093A DE102004023093B3 (de) 2004-05-05 2004-05-05 Trimere makrocyclisch substituierte Halogen-Benzolderivate

Publications (1)

Publication Number Publication Date
GT200500106A true GT200500106A (es) 2005-12-15

Family

ID=34967980

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200500106A GT200500106A (es) 2004-05-05 2005-05-04 Derivados de benceno halogenados sustituidos con trimeros macrociclicos

Country Status (18)

Country Link
US (1) US7385054B2 (es)
EP (1) EP1742926B1 (es)
JP (1) JP2007536295A (es)
AR (1) AR050984A1 (es)
AT (1) ATE369347T1 (es)
DE (2) DE102004023093B3 (es)
DK (1) DK1742926T3 (es)
ES (1) ES2289711T3 (es)
GT (1) GT200500106A (es)
PA (1) PA8632101A1 (es)
PE (1) PE20060350A1 (es)
PL (1) PL1742926T3 (es)
PT (1) PT1742926E (es)
SI (1) SI1742926T1 (es)
SV (1) SV2006002104A (es)
TW (1) TW200539894A (es)
UY (1) UY28884A1 (es)
WO (1) WO2005108379A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007058220A1 (de) 2007-12-03 2009-06-04 Bayer Schering Pharma Aktiengesellschaft Dimere macrocyclisch substituierte Benzolderivate
KR101209633B1 (ko) * 2009-09-09 2012-12-06 주식회사 휴메딕스 페길레이션된 삼요오드화 아릴 화합물 및 그를 포함하는 ｘ-선 조영제
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
WO2018096082A1 (en) 2016-11-28 2018-05-31 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
CA3120665A1 (en) 2018-11-23 2020-05-28 Bayer Aktiengesellschaft Formulation of contrast media and process of preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324503A (en) * 1992-02-06 1994-06-28 Mallinckrodt Medical, Inc. Iodo-phenylated chelates for x-ray contrast
WO1994027644A1 (en) * 1993-06-02 1994-12-08 Bracco S.P.A. Iodinated paramagnetic chelates, and their use as contrast agents
DE10307759B3 (de) * 2003-02-19 2004-11-18 Schering Ag Trimere makrocyclisch substituierte Benzolderivate, deren Herstellung und Verwendung als Kontrastmittel sowie diese enthaltende pharmazeutische Mittel
US7208140B2 (en) * 2003-02-19 2007-04-24 Schering Aktiengesellschaft Trimeric macrocyclic substituted benzene derivatives

Also Published As

Publication number Publication date
ATE369347T1 (de) 2007-08-15
TW200539894A (en) 2005-12-16
WO2005108379A1 (de) 2005-11-17
EP1742926A1 (de) 2007-01-17
DK1742926T3 (da) 2007-10-15
JP2007536295A (ja) 2007-12-13
PE20060350A1 (es) 2006-05-25
SV2006002104A (es) 2006-02-15
PL1742926T3 (pl) 2007-12-31
ES2289711T3 (es) 2008-02-01
UY28884A1 (es) 2005-11-30
AR050984A1 (es) 2006-12-13
PT1742926E (pt) 2007-09-24
US20060154989A1 (en) 2006-07-13
SI1742926T1 (sl) 2007-12-31
PA8632101A1 (es) 2006-07-03
EP1742926B1 (de) 2007-08-08
US7385054B2 (en) 2008-06-10
DE102004023093B3 (de) 2006-03-02
DE502005001194D1 (de) 2007-09-20

Similar Documents

Publication Publication Date Title
GT200600430A (es) Compuestos de carboxiamina y metodos de uso de los mismos
GT200500103A (es) 4-fenilamino-quinazolin-6-il-amidas
GT200500226A (es) Compuestos de aminoheteroarilo sustituidos con pirazol como inhibidores de proteina quinasa
GT200600339A (es) Inhibidores macrociclicos del virus de la hepatitis c
GT200800103A (es) 5-aril isoxazolinas para controlar plagas de invertebrados
GT200600181A (es) Derivados de amida sustituida y metodos de uso
GT200600174A (es) Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion
GT200500272A (es) 2-anilinopirimidinas sustituidas como inhibidores de la quinasa del ciclo celular o del receptor de la tirosina quinasa, su preparacion y su uso como medicamentos
GT200300296A (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
GT200600428A (es) Compuestos organicos
GT200600205A (es) Nuevos herbicidas
GT200800258A (es) Compuestos de pirrolo-pirimidina y sus usos
GT200500242A (es) Procesos para la preparaciòn de 2-(2,6-dioxopiperidin-3-il)-1-oxoisoindolinas sustituidas
GT200700077A (es) Compuestos de 4-metilpiridopirimidinona
GT200500159A (es) (orto-fenil)-anilidas de àcido 1-metil-3-trifluorometil-pirazol-4-carboxìlico y su uso como fungicida
GT200600024A (es) Derivados de triazol sustituidos como antagonistas de oxitocina
GT200500292A (es) Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica
GT200600422A (es) Derivados de carboxamida como antagonistas del receptor muscarinico
GT200700058A (es) Nuevos derivados de piridazina
CR10060A (es) 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas
BRPI0605926A2 (pt) ciclopentanos substituìdos ou ciclopentanonas como agentes terapêuticos
GT200200269A (es) Derivados de 7-amino-benzotiazol
DOP2006000087A (es) Compuestos heteroaromaticos acilaminobiciclicos y sus usos
GT200400188A (es) 5-arilpirimidinas como agentes anticancerigenos
GT200600326A (es) Diazepinoquinolinas, sintesis de las mismas e intermediarios de las mismas